Literature DB >> 18314425

Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct.

Mike Mitka.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18314425     DOI: 10.1001/jama.299.8.885

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  What are biomarkers?

Authors:  Kyle Strimbu; Jorge A Tavel
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 2.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

3.  Low molecular weight galactomannans-based standardized fenugreek seed extract ameliorates high-fat diet-induced obesity in mice via modulation of FASn, IL-6, leptin, and TRIP-Br2.

Authors:  Amit D Kandhare; Debasish Bandyopadhyay; Prasad A Thakurdesai
Journal:  RSC Adv       Date:  2018-09-18       Impact factor: 4.036

4.  Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?

Authors:  Michel de Lorgeril; Patricia Salen; Pascal Defaye; Mikael Rabaeus
Journal:  BMC Med       Date:  2013-01-04       Impact factor: 8.775

5.  Bias, spin, and misreporting: time for full access to trial protocols and results.

Authors:  An-Wen Chan
Journal:  PLoS Med       Date:  2008-11-25       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.